Across TCGA pan-cancer cohorts, IFNA12P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of IFNA12P’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where IFNA12P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types IFNA12P is over-expressed in tumor.
THCA are the cancer types where IFNA12P tumor–normal differential expression is most reproducible.